Tandem Diabetes Care (NSDQ:TNDM) said today that it raised roughly $115 million from an underwritten public offering.
The San Diego, Calif.-based company offered 3,508,770 shares of its common stock at $28.50 apiece. Underwriters fully exercised an option to buy 526,315 additional shares of common stock, Tandem noted.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem reels in $115m from public offering appeared first on MassDevice.
from MassDevice https://ift.tt/2ASff9N
Cap comentari:
Publica un comentari a l'entrada